FRMD6 and breast cancer: Metformin, a well-known drug for the treatment of hyperglycemia [27,28], increases Willin/FRMD6 levels in Tamoxifen and paclitaxel sensitive breast cancer cells [29], suggesting that Willin/FRMD6 modulation may occur in response to glucose.